# EDGAR Filing Document

**Accession Number:** 0001802255
**File Stem:** 0001193125-26-116116
**Filing Date:** 2026-3
**Character Count:** 15044
**Document Hash:** ad1053ed50a034386ee5d0c78ce3e119
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-116116.hdr.sgml**: 20260319

**ACCESSION NUMBER**: 0001193125-26-116116

**CONFORMED SUBMISSION TYPE**: S-3MEF

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20260319

**DATE AS OF CHANGE**: 20260319

**EFFECTIVENESS DATE**: 20260319

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Guardian Pharmacy Services, Inc.
- **CENTRAL INDEX KEY:** 0001802255
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 200100834
- **STATE OF INCORPORATION:** GA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-3MEF
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-294447
- **FILM NUMBER:** 26774909

**BUSINESS ADDRESS:**
- **STREET 1:** 300 GALLERIA PARKWAY SE
- **STREET 2:** SUITE 800
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30339
- **BUSINESS PHONE:** (404) 810-0089

**MAIL ADDRESS:**
- **STREET 1:** 300 GALLERIA PARKWAY SE
- **STREET 2:** SUITE 800
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30339

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Guardian Pharmacy, LLC
- **DATE OF NAME CHANGE:** 20200204

**As filed with the Securities and Exchange Commission on March 19, 2026** 

**Registration No. 333-** 

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM S-3** 

**REGISTRATION STATEMENT** 

***UNDER***

***THE SECURITIES ACT OF 1933***

## GUARDIAN PHARMACY SERVICES, INC.
**(Exact name of registrant as specified in its charter)** 

---

| | | |
|:---|:---|:---|
| **Delaware** | **300 Galleria Parkway SE**<br> **Suite 800**<br> **Atlanta, Georgia 30339**<br> **(404) 810-0089** | **87-3627139** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)** | **(I.R.S. Employer**<br> **Identification Number)** |

---

**Fred Burke** 

**President and Chief Executive Officer** 

**Guardian Pharmacy Services, Inc.** 

**300 Galleria Parkway SE** 

**Suite 800** 

**Atlanta, Georgia 30339** 

**(404) 810-0089** 

**(Name, address, including zip code, and telephone number, including area code, of agent for service)** 

***Copies to:***

**Mark L. Hanson, Esq.** 

**Jones Day** 

**1221 Peachtree Street NE, Suite 400** 

**Atlanta, Georgia 30361** 

**(404) 521-3939** 

**Approximate date of commencement of proposed sale to the public:** From time to time after the effective date of the registration statement.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ (File No. 333-290865)

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**This Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) of the Securities Act.** 

------

**EXPLANATORY NOTE AND INCORPORATION BY REFERENCE** 

This Registration Statement on Form S-3 (this "Registration Statement") is being filed with respect to the registration of 900,000 additional shares of Class A common stock, par value $0.001 per share (the "Class A common stock") of Guardian Pharmacy Services, Inc. (the "Registrant"), pursuant to Rule 462(b) under the Securities Act of 1933, as amended (the "Securities Act"), and General Instruction IV(A) of Form S-3. This Registration Statement relates to the Registrant's Registration Statement on Form S-3 (No. [333-290865](http://www.sec.gov/Archives/edgar/data/1802255/000119312525239027/d64107ds3.htm)) (the "Prior Registration Statement"), which was filed with the Securities and Exchange Commission on October 14, 2025 and became effective on November 3, 2025 pursuant to Section 8(a) of the Securities Act.

The Registrant is filing this Registration Statement for the sole purpose of increasing the aggregate number of shares of Class A common stock offered by the selling stockholders in the Prior Registration Statement by 900,000 shares of Class A common stock. The shares of Class A common stock being registered hereunder are in addition to the 4,980,000 shares of Class A common stock offered by the selling stockholders and the 1,020,000 shares of Class A common stock offered by the Registrant that were registered under the Prior Registration Statement. The additional shares that are being registered under this Registration Statement are in an amount and at a price that together represent no more than 20% of the maximum aggregate offering price set forth in the Calculation of Filing Fee Tables contained in the Prior Registration Statement.

The required opinion and consents are filed herewith. Pursuant to Rule 462(b) of the Securities Act, the contents of the Prior Registration Statement, including the exhibits thereto, are incorporated by reference into this Registration Statement.

------

**EXHIBIT INDEX** 

---

| | |
|:---|:---|
| **Exhibit**<br>**Number** | **Exhibit Description** |
| 5.1 | [Opinion of Jones Day](d20163dex51.htm) |
| 23.1 | [Consent of Ernst & Young LLP](d20163dex231.htm) |
| 23.2 | [Consent of Jones Day (included in Exhibit 5.1)](d20163dex51.htm) |
| 24.1 | [Power of Attorney (incorporated by reference to Exhibit 24.1 to the Prior Registration Statement)](http://www.sec.gov/Archives/edgar/data/1802255/000119312525239027/d64107ds3.htm#sig) |
| 107.1 | [Calculation of Filing Fee Table](d20163dexfilingfees.htm) |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Atlanta, State of Georgia, on March 19, 2026.

---

| | |
|:---|:---|
|  | **Guardian Pharmacy Services, Inc.** |
|  By: | /s/ Fred P. Burke |
|  | Fred P. Burke |
|  | President and Chief Executive Officer |

---

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated:

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Fred P. Burke<br> Fred P. Burke | President and Chief Executive Officer and Director<br> (Principal Executive Officer) | March 19, 2026 |
| \*<br> David Morris | Executive Vice President, Chief Financial Officer and Director<br> (Principal Financial Officer and<br> Principal Accounting Officer) | March 19, 2026 |
| \*<br> John Ackerman | Director | March 19, 2026 |
| \*<br> William Bindley | Director | March 19, 2026 |
| \*<br> Steve Cosler | Director | March 19, 2026 |
| \*<br> Randall Lewis | Director | March 19, 2026 |
| \*<br> Mary Sue Patchett | Director | March 19, 2026 |
| \*<br> Thomas Salentine, Jr. | Director | March 19, 2026 |

---

---

| | |
|:---|:---|
|  \*By: | /s/ Fred P. Burke |
|  | Fred P. Burke |
|  | Attorney-in-Fact |

---

## Exhibit 5.1

**Exhibit 5.1**![LOGO](g20163g0320004928819.jpg)

1221 PEACHTREE STREET, N.E. • SUITE 400 • ATLANTA, GEORGIA 30361

TELEPHONE: +1.404.521.3939 • JONESDAY.COM

March 19, 2026

Guardian Pharmacy Services, Inc.

300 Galleria Parkway SE

Suite 800

Atlanta, Georgia 30339

Re: <u>Registration Statement on Form S-3</u>

Ladies and Gentlemen:

We have acted as counsel for Guardian Pharmacy Services, Inc., a Delaware corporation (the "***Company***"), in connection with the registration for resale from time to time, on a continuous or delayed basis, of up to 900,000 shares of Class A common stock, par value $0.001 per share (the "***Additional Shares***"), by certain selling stockholders, as contemplated by the Company's Registration Statement on Form S-3 to which this opinion is filed as an exhibit (the "***462(b) Registration Statement***").

In connection with the opinion expressed herein, we have examined such documents, records and matters of law as we have deemed relevant or necessary for purposes of such opinion. Based on the foregoing and subject to the further limitations, qualifications and assumptions set forth herein, we are of the opinion that the Additional Shares have been validly issued and are fully paid and nonassessable.

The opinion expressed herein is limited to the General Corporation Law of the State of Delaware, as currently in effect, and we express no opinion as to the effect of the laws of any other jurisdiction on the opinion expressed herein.

We hereby consent to the filing of this opinion as Exhibit 5.1 to the 462(b) Registration Statement. In giving such consent, we do not hereby admit that we are included in the category of persons whose consent is required under Section 7 of the Securities Act of 1933 or the rules and regulations of the Securities and Exchange Commission promulgated thereunder.

---

| |
|:---|
| Very truly yours, |
| /s/ Jones Day |

---

![LOGO](g20163g89b56.jpg)

## Exhibit 23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement on Form S-3 filed pursuant to Rule 462(b) of the Securities Act of 1933 of the reference to our firm under the caption "Experts" and to the incorporation by reference of our reports dated March 11, 2026, with respect to the consolidated financial statements of Guardian Pharmacy Services, Inc., and the effectiveness of internal control over financial reporting of Guardian Pharmacy Services, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2025, filed with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

Atlanta, Georgia

March 19, 2026

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

---

| |
|:---|
| **Calculation of Filing Fee Tables**  |
| &nbsp;&nbsp;&nbsp;&nbsp;**S-3**  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Guardian Pharmacy Services, Inc.**  |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Security Type**  | **Security Class Title**  | **Fee Calculation or Carry Forward Rule**  | **Amount Registered**  | **Proposed Maximum Offering Price Per Unit**  | **Maximum Aggregate Offering Price**  | **Fee Rate**  | **Amount of Registration Fee**  |
| **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** |
| Fees to be Paid | 1 | Equity | Class A Common Stock, par value $0.001 per share | 457(o) | 900000 | $31.00 | $27900000.00 | 0.0001381 | $3852.99 |
| Fees Previously Paid |  |  |  |  |  |  |  |  |  |
| **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** |
| Carry Forward Securities |  |  |  |  |  |  |  |  |  |
|  |  |  | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: |  | $27900000.00  |  | $3852.99  |
|  |  |  | Total Fees Previously Paid:  | Total Fees Previously Paid:  | Total Fees Previously Paid:  |  |  |  | $0.00  |
|  |  |  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  |  |  |  | $0.00  |
|  |  |  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  |  |  |  | $3852.99  |

---

 **Offering Note** <br>

<sup>1</sup> (1) The registrant previously registered the offer and sale of 6,000,000 shares of its Class A Common Stock, par value $0.001 per share ("Class A Common Stock") pursuant to a Registration Statement on Form S-3 (File No. 333-290865) (the "Prior Registration Statement"), which was initially filed on October 14, 2025 and became effective on November 3, 2025 pursuant to Section 8(a) of the Securities Act, as amended (the "Securities Act"). In accordance with Rule 462(b) under the Securities Act, and General Instruction IV(A) of Form S-3, the registrant is hereby registering the offer and sale of an additional 900,000 shares of Class A Common Stock. The additional shares of Class A Common Stock that are being registered hereby for offer and sale represent no more than 20% of the maximum aggregate offering price set forth in the Calculation of Filing Fee Tables contained in the Prior Registration Statement. (2) Based on the public offering price of $31.00.

---

| |
|:---|
| |
| **Rules 457(b) and 0-11(a)(2)** |
| Fee Offset Claims |
| Fee Offset Sources |
| **Rule 457(p)** |
| Fee Offset Claims |
| Fee Offset Sources |

---